Hiroyoshi Y Tanaka

9PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer geneticsBiological network analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 29, 2026
High ZFP36 Family Expression in Exhausted T Cells Is Associated With Impaired Antitumor Effector Function.

|Feb 13, 2026
Bioinformatic Prediction of Activation States in Molecular Network Pathways of Eukaryotic Initiation Factor 2 (EIF2) Signaling and Coronavirus Pathogenesis.

Shihori Tanabe, Sabina Quader, Ryuichi Ono

|Nov 29, 2025
p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis.

Takeyoshi Nishiyama, Hiroshi Tazawa, Yasuo Nagai

|Oct 31, 2025
Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis.

Mayu Ohira, Moe Kitamura, Hiroyo Iwasaki

|Oct 17, 2025
Pan-cancer analysis of RNA expression signatures associated with cancer tissue architecture.

Megumi Mogi, Katsushige Kawase, Hiroyoshi Y Tanaka

|Jul 23, 2025
Artificial Intelligence Approach in Machine Learning-Based Modeling and Networking of the Coronavirus Pathogenesis Pathway.

Shihori Tanabe, Sabina Quader, Ryuichi Ono

Pageof 2

Frequent Collaborators

3 joint publications

Mitsunobu R Kano

3 joint publications

Shihori Tanabe

2 joint publications

Sabina Quader

1 joint publications

Kotaro Hayashi